This article is free to access.
This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin, hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing inpatient use.
Castro, N. E., García, D. R., Rivera, M. T., Rondán-Guerrero, P., García-Rojas, F., & Taype-Rondan, A. (2021). TRENDS IN DRUGS USAGE FOR COVID-19 DURING THE FIRST WAVE OF THE PANDEMIC IN A HOSPITAL IN LIMA, PERU. Revista Peruana de Medicina Experimental y Salud Publica, 38(4), 608–614. https://doi.org/10.17843/rpmesp.2021.384.8820